Penicillin G Acylase Market

Penicillin G Acylase Market (Source: E. coli, Bacillus Megaterium, and Others; Application: Production of Semisynthetic Penicillin, Production of Semisynthetic Cephalosporin, and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Penicillin G Acylase Market Outlook 2031

  • The global industry was valued at US$ 672.5 Mn in 2022
  • It is projected to grow at a CAGR of 5.6% from 2023 to 2031 and reach more than US$ 1.1 Bn by the end of 2031

Analysts’ Viewpoint

The global penicillin G acylase market is experiencing robust growth due to increase in demand for semisynthetic penicillin, such as ampicillin and amoxicillin, which have greater efficacy and reduced toxicity compared to natural penicillin. Increase in demand for antibiotics due to rise in prevalence of infectious diseases, surge in healthcare expenditure, and increase in research & development activities to improve effectiveness of penicillin G acylase are propelling market development.

Increase in demand for semi-synthetic penicillin and rise in demand for enzyme-based manufacturing processes are likely to provide lucrative opportunities for market players in the next few years. Companies are focusing on sustainable manufacturing processes for the development of cost-effective and environmentally friendly enzymes. However, availability of alternative antibiotics and high cost of enzyme production process are likely to restrain penicillin G acylase market demand.

Penicillin G Acylase Market

Global Penicillin G Acylase Market Introduction

Penicillin G acylase (PGA) is an enzyme utilized in the manufacture of semisynthetic antibiotics such as amoxicillin, ampicillin, and cephalosporins. Demand for PGA is driven by rise in need for antibiotics and advancements in the production processes that incorporate PGA.

Beta-lactams represent the most important group of antibiotics, and account for 65% of the global antibiotic market. There has been high and sustained interest in penicillin G acylase in the last few decades. Rise in demand for P-lactam antibiotics is fueling market expansion. Increasing demand for penicillin G acylase in the global antibiotics market is ascribed to its ability to catalytically hydrolyze penicillin G into phenylacetic acid and 6-amino penicillanic acid, as well as synthesize semi-synthetic antibiotics. Furthermore, penicillin G acylase enzyme is capable of hydrolyzing cephalosporin G to produce 7-Amino-3-methyl-3-cephem-4-carboxylic acid (7- ADCA). These two key intermediates—6-aminopenicillanic acid and 7-Amino-3-methyl-3-cephem-4-carboxylic acid—are essential components in the production of semi-synthetic beta lactam antibiotics.

The latest trends in the penicillin G acylase market include development of new and improved PGA-based production processes, such as immobilized PGA and use of recombinant DNA technology, to improve efficiency and reduce costs. There is also a growing interest in the usage of PGA in other applications, such as synthesis of chiral compounds for the pharmaceutical industry.

Increase in Incidence of Infectious Diseases

Rise in prevalence of infectious diseases is bolstering the global penicillin G acylase industry growth. Penicillin G acylase plays a significant role in the manufacture of semisynthetic penicillin, which is a commonly used class of antibiotics. Penicillin G acylase is an enzyme that speeds up the process of breaking down penicillin G into 6-aminopenicillanic acid (6-APA), a crucial intermediate in the synthesis of semisynthetic penicillin.

The global burden of infectious diseases has increased in the past few years due to various factors such as globalization, climate change, and antimicrobial resistance. Leading causes of morbidity and mortality globally, such as tuberculosis, malaria, and HIV/AIDS, are still prevalent, according to the World Health Organization (WHO). The need for effective treatment options has become more urgent, particularly with the emergence and spread of new infectious diseases such as COVID-19.

Semisynthetic penicillin is a vital tool in treating bacterial infections, as it offers better effectiveness and broader spectrum of activity than natural penicillin, making it suitable for treating a range of bacterial infections. Therefore, demand for semisynthetic penicillin is increasing, which in turn is driving the need for penicillin G acylase as a key enzyme in its production.

Higher Efficacy of Semisynthetic Penicillin Drugs

Increase in demand for semisynthetic penicillin is driving the global penicillin G acylase market. Semisynthetic penicillin is able to penetrate the bacterial cell wall more efficiently than natural penicillin due to the addition of chemical groups that enhance its ability to cross biological membranes. This enables it to achieve higher concentrations within bacterial cells, leading to better bacterial killing. Furthermore, the chemical modifications made in semisynthetic penicillin make it more resistant to degradation by bacterial enzymes, ensuring its activity for longer periods.

Semisynthetic penicillin also has a better safety profile compared to natural penicillin. It is less likely to cause allergic reactions and has lower nephrotoxicity and neurotoxicity, and is thus the preferred choice for treating bacterial infections in patients who are allergic or intolerant to natural penicillin.

E. Coli is Easy to Manipulate Genetically and Cost-effective

In terms of source, the E. coli segment dominated the global market in 2022. Microbial synthesis of PGA, either in its natural strain or in recombinant hosts, has received much attention, particularly for PGA from E. coli. Hence, extensive research & development activities to enhance the recovery rate are expected to drive the penicillin G acylase market in the next few years. E. coli is a well-studied and well-characterized bacterium that is easy to manipulate genetically, which makes it an ideal organism for genetic engineering to optimize the production of PGA. It can be engineered to express high levels of PGA and to secrete the enzyme into the culture medium, which simplifies downstream processing.

E. coli is a low-cost organism that can be grown in large-scale fermentations using inexpensive carbon and nitrogen sources. This makes production of PGA from E. coli a cost-effective process that can be scaled up to meet the demands of the pharmaceutical industry. It is a non-pathogenic bacterium that is considered safe for use in the production of pharmaceuticals. Usage of E. coli as a source of PGA has been approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA).

High Demand for Antibiotics Bolstering Production of Semisynthetic Penicillin

Based on application, the production of semisynthetic penicillin segment accounted for leading market share in 2022. Production of semisynthetic penicillin is one of the most important applications of penicillin G acylases. This is ascribed to high demand for antibiotics in the healthcare sector and several advantages of semisynthetic penicillin over other types of antibiotics.

Semisynthetic penicillin is produced by modifying the structure of natural penicillin using penicillin G acylases. The modification process can produce penicillin, which is more effective against certain types of bacteria, has a longer half-life in the body, or is less susceptible to resistance than natural penicillin. This makes semisynthetic penicillin a highly valuable tool in the fight against infectious diseases, which continue to be a major public health challenge worldwide.

Demand for penicillin G acylases is high in the healthcare sector, as these are an important tool in the production of several types of antibiotics, including semi-synthetic penicillin. As the global population continues to grow and age, demand for antibiotics is expected to increase, which is likely to offer lucrative business opportunities to market players.

Significant Resources and Expertise in Development & Production of Drugs

Based on end-user, the pharmaceutical companies segment led the global penicillin G acylase market in 2022. Penicillin G acylase is an enzyme used in the production of semisynthetic antibiotics, including ampicillin and amoxicillin. These antibiotics are widely used in the treatment of various bacterial infections, making them a vital component of the healthcare industry.

Pharmaceutical companies have significant resources and expertise in the development and production of drugs and pharmaceuticals. These have the necessary infrastructure, equipment, and technical know-how to develop and produce penicillin G acylase on a large scale, ensuring a reliable supply of the enzyme. These companies also have established distribution networks and sales channels that enable them to reach a broad customer base, including hospitals, clinics, and other healthcare facilities.

Pharmaceutical companies invest significantly in research & development to create new and innovative drugs and therapies. R&D often involves usage of penicillin G acylase in the production of new antibiotics, which further strengthens their position in the market.

Regional Outlook of Global Penicillin G Acylase Market

North America accounted for significant global penicillin G acylase market share in 2022. Rise in prevalence of infectious diseases, such as tuberculosis, malaria, and respiratory infections is driving the market in the region. These conditions often require antibiotics for the treatment, which contributes to the rise in demand for PGA during the forecast period.

The market in Europe is driven by high demand for PGA among leading pharmaceutical companies and rise in adoption of semisynthetic penicillin and cephalosporin. For instance, pharmaceutical companies in Europe such as Merck KGaA and Biosynth are the key players in the market. These are major providers of PGA to academic and research institutes, CMO, etc. for manufacturing of semisynthetic antibiotics.

Increase in labor, energy, and raw material costs has resulted in shift of bulk manufacturing to the East, with China, South Korea, and India becoming major production hubs. Hence, the market in Asia Pacific is projected to witness rapid growth during the forecast period.

The market in Latin America is growing at a sluggish pace. However, the market is expected to experience moderate growth due to increase in usage of PGA in the production of semisynthetic antibiotics and rise in prevalence of infectious diseases.

Analysis of Key Players

The global penicillin G acylase market is fragmented, with the presence of large number of players. Key players operating in the market are Merck KGaA, Fermenta Biotech Ltd., Biosynth, Amicogen, Creative Enzymes, Crawford Wisdom International, and MuseChem Chemicals. These players engage in merger & acquisition, strategic collaborations, and new product launches to expand presence and gain market share.

Key Developments in Global Penicillin G Acylase Market

  • In June 2022, Merck & Co.'s Anna Fryszkowska and Chihui An led a team of researchers who developed a new method inspired by protecting groups used by chemists to block certain species from reacting when creating complex small molecules. The team used directed evolution to engineer penicillin G acylase enzymes that cap each of insulin's amines selectively. The modified insulins are produced by applying these enzymatic caps, chemically modifying the uncapped amine, and finally removing the caps.

The market report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent developments.

Global Penicillin G Acylase Market Snapshot

Attribute

Detail

Size in 2022

US$ 672.5 Mn

Forecast Value in 2031

More than US$ 1.1 Bn

CAGR - 2022–2031

5.6%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Source
    • E. coli
    • Bacillus Megaterium
    • Others
  • Application
    • Production of Semisynthetic Penicillin
    • Production of Semisynthetic Cephalosporin
    • Others
  • End-user
    • Pharmaceutical Companies
    • Academic & Research Institutes
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Merck KGaA (Sigma Aldrich)
  • Fermenta Biotech Ltd.
  • Biosynth
  • Amicogen
  • Creative Enzymes
  • Crawford Wisdom International
  • MuseChem Chemicals

Frequently Asked Questions

How big was the global market in 2022?

The global industry was valued at US$ 672.5 Mn in 2022.

How big will it be in 2031?

It is projected to reach more than US$ 1.1 Bn by 2031.

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 5.6% from 2023 to 2031.

What was the share of the leading segment?

The E. coli held more than 80.0% share in 2022.

Which region will account for major share during the forecast period?

North America is expected to account for largest share from 2023 to 2031.

Who are the prominent players in the business?

Merck KGaA, Fermenta Biotech Ltd., Biosynth, Amicogen, Creative Enzymes, Crawford Wisdom International, and MuseChem Chemicals.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Penicillin G Acylase Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Penicillin G Acylase Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Penicillin G Acylase Preform and Immobilize form: An Overview

    5.2. Regulatory Scenario by Region/globally

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Penicillin G Acylase Market Analysis and Forecast, By Source

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Source, 2017–2031

        6.3.1. E. coli

        6.3.2. Bacillus Megaterium

        6.3.3. Others

    6.4. Market Attractiveness Analysis, By Source

7. Global Penicillin G Acylase Market Analysis and Forecast, By Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Production of Semisynthetic Penicillin

        7.3.2. Production of Semisynthetic Cephalosporin

        7.3.3. Others

    7.4. Market Attractiveness Analysis, By Application

8. Global Penicillin G Acylase Market Analysis and Forecast, By End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Pharmaceutical Companies

        8.3.2. Academic & Research Institutes

        8.3.3. Others

    8.4. Market Attractiveness Analysis, By End-user

9. Global Penicillin G Acylase Market Analysis and Forecast, By Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, By Region

10. North America Penicillin G Acylase Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Source, 2017–2031

        10.2.1. E. coli

        10.2.2. Bacillus Megaterium

        10.2.3. Others

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Production of Semisynthetic Penicillin

        10.3.2. Production of Semisynthetic Cephalosporin

        10.3.3. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Pharmaceutical Companies

        10.4.2. Academic & Research Institutes

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Source

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Penicillin G Acylase Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Source, 2017–2031

        11.2.1. E. coli

        11.2.2. Bacillus Megaterium

        11.2.3. Others

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Production of Semisynthetic Penicillin

        11.3.2. Production of Semisynthetic Cephalosporin

        11.3.3. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Pharmaceutical Companies

        11.4.2. Academic & Research Institutes

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Source

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Penicillin G Acylase Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Source, 2017–2031

        12.2.1. E. coli

        12.2.2. Bacillus Megaterium

        12.2.3. Others

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Production of Semisynthetic Penicillin

        12.3.2. Production of Semisynthetic Cephalosporin

        12.3.3. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Pharmaceutical Companies

        12.4.2. Academic & Research Institutes

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Source

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Penicillin G Acylase Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Source, 2017–2031

        13.2.1. E. coli

        13.2.2. Bacillus Megaterium

        13.2.3. Others

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Production of Semisynthetic Penicillin

        13.3.2. Production of Semisynthetic Cephalosporin

        13.3.3. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Pharmaceutical Companies

        13.4.2. Academic & Research Institutes

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Source

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Penicillin G Acylase Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Source, 2017–2031

        14.2.1. E. coli

        14.2.2. Bacillus Megaterium

        14.2.3. Others

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Production of Semisynthetic Penicillin

        14.3.2. Production of Semisynthetic Cephalosporin

        14.3.3. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Pharmaceutical Companies

        14.4.2. Academic & Research Institutes

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & South Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Source

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (by tier and size of companies)

    15.2. Company Profiles

        15.2.1. Merck KGaA (Sigma Aldrich)

            15.2.1.1. Company Overview

            15.2.1.2. Financial Overview

            15.2.1.3. Product Portfolio

            15.2.1.4. Business Strategies

            15.2.1.5. Recent Developments

        15.2.2. Fermenta Biotech Ltd.

            15.2.2.1. Company Overview

            15.2.2.2. Financial Overview

            15.2.2.3. Product Portfolio

            15.2.2.4. Business Strategies

            15.2.2.5. Recent Developments

        15.2.3. Biosynth

            15.2.3.1. Company Overview

            15.2.3.2. Financial Overview

            15.2.3.3. Product Portfolio

            15.2.3.4. Business Strategies

            15.2.3.5. Recent Developments

        15.2.4. Amicogen

            15.2.4.1. Company Overview

            15.2.4.2. Financial Overview

            15.2.4.3. Product Portfolio

            15.2.4.4. Business Strategies

            15.2.4.5. Recent Developments

        15.2.5. Creative Enzymes

            15.2.5.1. Company Overview

            15.2.5.2. Financial Overview

            15.2.5.3. Product Portfolio

            15.2.5.4. Business Strategies

            15.2.5.5. Recent Developments

        15.2.6. Crawford Wisdom International

            15.2.6.1. Company Overview

            15.2.6.2. Financial Overview

            15.2.6.3. Product Portfolio

            15.2.6.4. Business Strategies

            15.2.6.5. Recent Developments

        15.2.7. MuseChem Chemicals

            15.2.7.1. Company Overview

            15.2.7.2. Financial Overview

            15.2.7.3. Product Portfolio

            15.2.7.4. Business Strategies

            15.2.7.5. Recent Developments

List of Tables

Table 01: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 02: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 06: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 07: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country, 2017‒2031

Table 09: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 10: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 11: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017‒2031

Table 13: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 14: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

Table 17: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 18: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

Table 21: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017‒2031

Table 22: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

List of Figures

Figure 01: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Penicillin G Acylases Market Value Share, by Source, 2022

Figure 03: Global Penicillin G Acylases Market Value Share, by Application, 2022

Figure 04: Global Penicillin G Acylases Market Value Share, by End-user, 2022

Figure 05: Global Penicillin G Acylases Market Value Share Analysis, by Source, 2022 and 2031

Figure 06: Global Penicillin G Acylases Market Attractiveness Analysis, by Source, 2023–2031

Figure 07: Global Penicillin G Acylases Market Value (US$ Mn), by E. coli, 2017‒2031

Figure 08: Global Penicillin G Acylases Market Value (US$ Mn), by Bacillus Megaterium, 2017‒2031

Figure 09: Global Penicillin G Acylases Market Value (US$ Mn), by Others, 2017‒2031

Figure 10: Global Penicillin G Acylases Market Value Share Analysis, by Application, 2022 and 2031

Figure 11: Global Penicillin G Acylases Market Attractiveness Analysis, by Application, 2022–2031

Figure 12: Global Penicillin G Acylases Market Revenue (US$ Mn), by Production of Semisynthetic Penicillin, 2017–2031

Figure 13: Global Penicillin G Acylases Market Revenue (US$ Mn), by Production of Semisynthetic Cephalosporin, 2017–2031

Figure 14: Global Penicillin G Acylases Market Revenue (US$ Mn), by Others, 2017–2031

Figure 15: Global Penicillin G Acylases Market Value Share Analysis, by End-user, 2022 and 2031

Figure 16: Global Penicillin G Acylases Market Attractiveness Analysis, by End-user, 2023–2031

Figure 17: Global Penicillin G Acylases Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2031

Figure 18: Global Penicillin G Acylases Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031

Figure 19: Global Penicillin G Acylases Market Revenue (US$ Mn), by Others, 2017–2031

Figure 20: Global Penicillin G Acylases Market Value Share Analysis, by Region, 2022 and 2031

Figure 21: Global Penicillin G Acylases Market Attractiveness Analysis, by Region, 2023–2031

Figure 22: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: North America Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031

Figure 24: North America Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023–2031

Figure 25: North America Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031

Figure 26: North America Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023–2031

Figure 27: North America Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031

Figure 28: North America Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023–2031

Figure 29: North America Penicillin G Acylase Market Value Share Analysis, by Country, 2022 and 2031

Figure 30: North America Penicillin G Acylase Market Attractiveness Analysis, by Country, 2023–2031

Figure 31: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Europe Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031

Figure 33: Europe Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023–2031

Figure 34: Europe Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031

Figure 35: Europe Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023–2031

Figure 36: Europe Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031

Figure 37: Europe Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023–2031

Figure 38: Europe Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 39: Europe Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 40: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017–2031

Figure 41: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031

Figure 42: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023–2031

Figure 43: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031

Figure 44: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023–2031

Figure 45: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031

Figure 46: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023–2031

Figure 47: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 48: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 49: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017–2031

Figure 50: Latin America Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031

Figure 51: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023–2031

Figure 52: Latin America Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031

Figure 53: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023–2031

Figure 54: Latin America Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031

Figure 55: Latin America Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023–2031

Figure 56: Latin America Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 57: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 58: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017–2031

Figure 59: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031

Figure 60: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023–2031

Figure 61: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031

Figure 62: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023–2031

Figure 63: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031

Figure 64: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023–2031

Figure 65: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 66: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved